ECTRIMS NeuroNews is our official blog for two information-sharing channels: MS Research Spotlight, which share and analysis the latest research about some the most relevant issues facing the MS community today; and our ECTRIMS News, which includes updates and news on the latest developments in our ECTRIMS activities and events.
ECTRIMS NeuroNews
ECTRIMS NeuroNews
ECTRIMS-EAN Vaccination Consensus Statement (eanCast)
The following episode has been produced by the European Academy of Neurology (EAN) in collaboration ...read more
German Neurologist Wins 2024 Rachel Horne Prize for Women’s Research in MS
Professor Kerstin Hellwig is being honoured for her pioneering research into understanding and navigating the ...read more
Research Updates: August 2024
Latest developments in MS research: Read about the consensus statement on smouldering-associated worsening in ...read more
Prodromal stage of multiple sclerosis: An opportunity to intervene?
In the five years before symptoms of multiple sclerosis (MS) appear, adults start visiting hospitals ...read more
Episode 34: Environmental, Genetic, and Epigenetic Risk Factors in MS
Multiple sclerosis (MS) is a complex and multifaceted neurological disorder. While MS has a genetic ...read more
Prof. Xavier Montalban on the Revised McDonald Criteria: A New Era in MS Diagnosis & Management
The announcement of the revised McDonald Criteria is eagerly anticipated within the MS community, and ...read more
Connecting Patients with Cutting-Edge Research in MS, MOGAD, and NMOSD
Join us at the 3rd annual Patient Community Day in Copenhagen this September, where we ...read more
Prof. Christine Lebrun-Frenay: Understanding Radiologically Isolated Syndromes
Confavreux Lecturer Christine Lebrun-Frenay, Head of Neurology at the Centre Hospitalier Universitaire de Nice, will ...read more
Research Updates: July 2024
Latest developments in MS research: Read about the prevalence of elevated concentration of serum neurofilament ...read more
Episode 33: Myelin Plasticity and Repair
The next major step forward in the management of MS involves finding treatments that can ...read more
Living well through menopause with MS
Menopause is a natural phase in a woman’s reproductive cycle, characterised by the permanent cessation ...read more
Inaugural Pre-Day on Neuroinflammatory Diseases
This year’s ECTRIMS congress will play host to the inaugural Pre-Day, giving members of the ...read more
Patient Community Day: Elevating Patient Voices
Join us at the 3rd annual Patient Community Day in Copenhagen this September, where we ...read more
Research Updates: June 2024
Latest developments in MS research: Learn how STING activation regulates the neuronal inflammatory stress response ...read more
Why attend ECTRIMS 2024
Three days of highly informative sessions, numerous networking opportunities, and various chances to showcase your ...read more
Episode 32: Lifestyle Modifications in MS
People living with MS want to be able to improve their quality of life and ...read more
Webinar Highlights: De-escalation and Discontinuation of DMTs
Disease-modifying therapies (DMTs) are the standard care for individuals with multiple sclerosis (MS). A better ...read more
NMOSD and MOGAD: Considerations about Diagnosis and Treatment
Early reports of neuromyelitis optica (NMO) can be traced back to the 19th century. In ...read more
Patient Community Day: Bridging the Gap Between Science and Experience
Tearing down silos, fostering partnerships, and placing people living with multiple sclerosis and related neurological ...read more
Episode 31: The Impact of Ageing on MS
While multiple sclerosis (MS) has been traditionally described as a disease of young adults, the ...read more
Research Updates: May 2024
Latest developments in MS research: Read about a new framework for guiding research on physical ...read more
Webinar Highlights: Cutting-edge Discussions on MS Therapies
How early is early enough to start treatment for multiple sclerosis (MS)? With the high-efficacy ...read more
Ageing and MS: Workshop Takeaways
A workshop on ageing and multiple sclerosis (MS) took place in Philadelphia in April, organised ...read more
Episode 30: Artificial Intelligence in MS Research
Artificial intelligence (AI) can be a powerful tool to help enhance our understanding of MS ...read more
Webinar Highlights: Exploring Ageing and MS
“This morning we diagnosed a patient of 89-year-old with a first attack of multiple sclerosis ...read more
Research Updates: April 2024
Latest developments in multiple sclerosis (MS) research: Read about the association between synaptic loss in ...read more
2024 Fellowship Recipients Announced
Seven early-career members of the MS community are about to embark on the professional adventure ...read more
Episode 29: Prioritising Women’s Health Topics in MS Research
In a landscape where funding is increasingly difficult to obtain, the importance of conducting research ...read more
Embracing diversity in MS clinical care and research
Every patient carries a unique personal story. Every story is a multifaceted tapestry formed by ...read more
MSMilan2023 Best Young Investigator Award Winner – Matteo Betti
Watch Dr. Matteo Betti from the University Hospital in Florence, Italy, discuss his award-winning oral ...read more
Episode 28: Spotlight on Young MS Researchers
The ECTRIMS Congress offers a valuable opportunity for young researchers to gain experience and exposure. ...read more
Research Updates: March 2024
Latest developments in MS research: Read about how to improve acute risk stratification when people ...read more
Managing migraine in people with MS
Migraine is generally considered a common condition in people living with multiple sclerosis (MS) [1]. ...read more
MSMilan2023 Abstract Winner – Ahmed Abdelhak
Watch Dr. Ahmed Abdelhak from the University of California, San Francisco, discuss his award-winning abstract ...read more
Priority setting: Women’s health topics in multiple sclerosis
Throughout their lives, women experience important changes associated with their reproductive cycle. When living with ...read more
Webinar Highlights: Pregnancy treatment and therapies for MS, NMOSD, and MOGAD
During our recent webinar, an expert panel discussed the safety and efficacy of different treatment ...read more
Call for Submissions – Rachel Horne Prize for Women’s Research in MS 2024
ECTRIMS is excited to announce the opening of submissions for the prestigious “Rachel Horne Prize ...read more
Episode 27: MS in the Black Community
With the growing push towards taking a more personalised approach to the treatment and management ...read more
MSMilan2023 Abstract Award Winner – Dejan Jakimovski
Watch Prof. Dejan Jakimovski of University at Buffalo talk about his award winning abstract poster ...read more
Submit Your Abstract for ECTRIMS 2024
Leave your mark at the world’s largest MS research congress and allow us to display ...read more
ECTRIMS Joins Forces with EMSP’s One Million Minds Campaign
ECTRIMS is proud to announce its endorsement of the European Multiple Sclerosis Platform’s (EMSP’s) One ...read more
Research Updates: February 2024
Latest developments in MS research: Read about the causal association between vitamin D receptor binding ...read more
Get to Know the MSMilan2023 Young Investigator Award Winners
ECTRIMS Congresses represent a great outlet for emerging investigators to feel part of a bigger ...read more
Meet the MSMilan2023 Poster Award Winners
Last year, at MSMilan2023, five young investigators won the “Poster Award” for the best poster ...read more
MSMilan2023 Poster Award Winner – Joonas Lehikoinen
Watch Joonas Lehikoine of University of Helsinki talk about his award winning abstract poster at ...read more
Accessing MS treatment for all: an update into MSIF’s successful WHO Essential Medicines List bid
During our recent webinar, an international panel of experts recounted the journey undertaken by the ...read more
Cognitive rehabilitation in multiple sclerosis
“Today my attention moves in fits and starts. My memory has broken legs, perhaps it ...read more
Episode 26: Efforts Towards a Better MS Diagnostic Criteria
Discussions are ongoing to change the way MS patients are diagnosed and treated. In this ...read more
Episode 25: Factoring in Female Health in the MS Journey
Recent global epidemiological data show that approximately 70% of people diagnosed with multiple sclerosis are ...read more
Research Updates: January 2024
Latest developments in MS research: Read about the possible inclusion of the optic nerve as ...read more
The impact of ageing on multiple sclerosis
Life expectancy is increasing worldwide. Nowadays, people live at least 6 years longer compared to ...read more
Episode 24: The Importance of Patient Community Day
The MSMilan Patient Community Day was designed for people living with multiple sclerosis and related ...read more
Research Updates: December 2023
Latest developments in MS research: Learn about the effect of a low-fat diet on fatigue ...read more
Treatment screening and monitoring: the importance of infectious diseases
One of the Hot Topics under discussion during the recent 9th Joint ECTRIMS-ACTRIMS Meeting, #MSMilan2023, ...read more
Episode 23: Genetics and MS Severity
Why do some people with multiple sclerosis (MS) continue to run marathons while others are ...read more
Episode 22: Defining MS Subtypes in Clinical Practice
Descriptors of multiple sclerosis are currently based on a combination of clinical and MRI features, ...read more
Research Updates: November 2023
Latest developments in MS research: Learn about the efficacy and safety of autologous stem cell ...read more
Episode 21: The Changing Role of MS Nurses
At MSMilan2023, the role of MS nurses was highlighted in two sessions. In this episode, ...read more
Future therapeutic strategies for individuals with MS
During the recent 9th Joint ECTRIMS-ACTRIMS Meeting, #MSMilan2023, future therapeutic strategies for individuals with MS ...read more
Episode 20: Discontinuing DMTs in Patients with Stable Relapsing-remitting MS: When and How?
Long term use of disease modifying treatments (DMTs) poses challenges in terms of safety and ...read more
MSMilan2023: Scientific and Clinical Highlights
The three days of MSMilan2023 featured hundreds of lectures, presentations, symposia, and posters – and ...read more
Survey finds overwhelming support for new MS clinical course descriptors
Almost 80% of respondents to an International Advisory Committee on Clinical Trials in Multiple Sclerosis ...read more
Charcot Lecture: A New Look at Diagnosing MS
“We were treating MS patients with nothing until 1995”. At the Plenary II Session at ...read more
MSMilan Patient Community Day
On 14 OctobAdd newer 2023 at Allianz Mico in Milan, Italy, a free, livestream event ...read more
MSMilan Patient Community Day – Italian Translation
Il 14 ottobre 2023 presso Allianz Mico a Milano, Italia, si è tenuto un evento ...read more
MSMilan Patient Community Day – German Translation
Am 14. Oktober 2023 fand im Allianz MiCo in Mailand, Italien, eine kostenlose Livestream-Veranstaltung für ...read more
MSMilan Patient Community Day – Spanish Translation
El 14 de octubre de 2023 en Allianz Mico en Milán, Italia, se llevó a ...read more
MSMilan Patient Community Day: Portuguese Translation
Em 14 de outubro de 2023, na Allianz Mico em Milão, Itália, foi realizado um ...read more
MSMilan Patient Community Day – French Translation
Le 14 octobre 2023, à l’Allianz Mico de Milan, en Italie, un événement gratuit et ...read more
Statement from ECTRIMS on the Situation in Israel and Gaza
Press Release | 24 October 2023 ECTRIMS wishes to express our deep concern for all ...read more
ECTRIMS Lecture: Paving the Way to a Cure
Growing understanding of the pathology and underlying mechanisms of MS has brought the prospect of ...read more
Episode 19: MSMilan2023 – Day 3 Highlights
ECTRIMS president Mar Tintoré wraps up MSMilan2023, and provides a glimpse into what to expect ...read more
Episode 18: MSMilan2023 – Day 2 Highlights
Listen to Clare Walton with MS Society UK and host Brett Drummond discuss the key ...read more
Episode 17: MSMilan2023 – Day 1 Highlights
ECTRIMS Lecturer Dr. Stephen Hauser – Fishman Distinguished Professor of Neurology at the University of ...read more
9th Joint ECTRIMS-ACTRIMS Meeting, MSMilan2023, Sets the Stage for Cutting-Edge Multiple Sclerosis Research and Collaboration
MSMilan2023 – the highly anticipated 9th Joint Meeting of the European Committee for Treatment and ...read more
Prof. Kerstin Hellwig: The use of DMTs during pregnancy & breastfeeding
With multiple sclerosis (MS) disproportionately affecting women of childbearing age, breastfeeding is a high-agenda topic ...read more
Exercise as a therapeutic intervention in multiple sclerosis
By ECTRIMS Contributing Writer Stefania de Vito Physical activity is undoubtably a potent medicine [1]. ...read more
Research Updates: September 2023
Latest developments in MS research: Learn about whether postpartum treatment with anti-CD20 mAbs is well-tolerated ...read more
Connecting nurses to the MS research community
Nurses are vital to the treatment and care of people living with MS. But amid ...read more
Prof. Stephen Hauser: Paving the Way to a Cure
Dr Stephen Hauser, Distinguished Professor of Neurology at University of California, San Francisco (UCSF), will ...read more
Episode 16: Behind the landmark WHO decision on essential medicines for MS
Multiple sclerosis (MS) treatments have been successfully added to the World Health Organisation’s Essential Medicines ...read more
Prof. Cristina Granziera: The use of AI in MS research
Artificial intelligence (AI) is undoubtedly a prominent topic in modern technology, sparking discussions and advancements. ...read more
How should we be managing older people with MS?
The number of older people living with MS is growing, due in large parts to ...read more
Dr. Rhonda Voskuhl Wins Inaugural Rachel Horne Prize
In a groundbreaking recognition of her remarkable contributions to multiple sclerosis (MS) research, Dr. Rhonda ...read more
Consensus report: How to improve the efficiency, quality, and relevance of your MS clinical trial
Helping people with multiple sclerosis (MS) live their lives to the fullest starts with proving ...read more
Precision-medicine biomarkers for multiple sclerosis: where do we stand?
By ECTRIMS Contributing Writer Stefania de Vito Like roses in the vineyard, biomarkers could play ...read more
MSMilan2023: Is AI ready for Primetime in MS Management?
As hot topics go, artificial intelligence (AI) is up there with the most talked about ...read more
Have your say on the future of women’s health in MS research
Researchers need your help to fill the knowledge gaps that leave women with MS and their ...read more
Hormone Replacement Therapy in MS
Around 30% of women with multiple sclerosis (MS) are peri- or post-menopausal[1], yet our understanding ...read more
Research Updates: August 2023
Latest developments in MS research: Learn about the weaker immune response and decreased booster efficacy ...read more
ECTRIMS to Host Global Patient-Community Event – Sharing Research in Multiple Sclerosis and Related Neurological Conditions
ECTRIMS will host MSMilan Patient Community Day on Saturday 14 October 2023, 15:00–17:00 CEST, at ...read more
Are breastfeeding and MS DMTs mutually exclusive?
With multiple sclerosis (MS) disproportionately affecting women of childbearing age, breastfeeding is a high-agenda topic ...read more
2024 Winter School: Body Fluid Biomarkers in Diagnosis, Management and Research of Multiple Sclerosis: From Bench to Bedside
Maximising social and environmental responsibility at MSMilan2023
A community garden dedicated to promoting sustainability and social cohesion has been chosen as this ...read more
Episode 15: Women with MS
MS affects more women than men. Research on the reasons behind this, and if and ...read more
Exploring the Link Between EBV and MS
Researchers have long believed that multiple sclerosis (MS) risk factors include infectious agents including Epstein-Barr ...read more
Research Updates: June-July 2023
Latest developments in MS research: Learn about association between anti-CD20 therapies and COVID-19 severity among ...read more
Understanding the associations between inflammatory disease activity and age in MS
At the 9th Joint ECTRIMS-ACTRIMS Meeting in October, the nuances of MS in the elderly ...read more
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
On Wednesday, 26 July 2023, the World Health Organisation (WHO) added disease modifying-therapies (DMTs) for ...read more
Episode 14: Utilising Global Data Registries for MS Research
The development of global databases that record and store large amounts of clinical data for ...read more
Understanding PIRA in Multiple Sclerosis
Detailed exploration of studies evaluating the use of highly effective treatments have unveiled the clinical ...read more
European Committee for Treatment and Research in MS and European Academy of Neurology Releases Consensus Statement on Vaccination Strategies for People with Multiple Sclerosis
The European Committee for Treatment and Research in Multiple Sclerosis, in collaboration with the European ...read more
Progression Independent of Relapses (PIRA): Existing Knowledge and Avenues for Research
Highlighting new research and increasing knowledge around multiple sclerosis is central to our mission at ...read more
The High-Efficacy DMT in MS Debate: When and Whom to Treat?
The advent of high-efficacy MS therapies has brought tremendous benefits, as well as huge debate ...read more
ECTRIMS fellowship 2023 winners
Projects to improve the prediction of disease course and personalisation of MS care, and to ...read more
Research Updates: May 2023
Latest developments in MS research: Learn about new population-based estimates for the prevalence of multiple ...read more
World MS Day 2023: A message from ECTRIMS and its global TRIMS partners
This 30 May, ECTRIMS is proud to support World MS Day with its TRIMS partners ...read more
Predicting the “network collapse”: an opportunity for developing mechanism-driven treatment decisions
By ECTRIMS Contributing Writer Stefania de Vito Our brain boasts an extensive web of neural ...read more
Episode 13: Epstein-Barr Virus and Multiple Sclerosis
A longitudinal study published in 2022 found that infection with the Epstein-Barr virus (EBV) dramatically ...read more
Research Updates: April 2023
Latest developments in MS research: two new studies offer fresh insights on how clinicians may ...read more
ECTRIMS 2022 Poster Prize Winner Sarmad Al-Araji
Watch Sarmad Al-Araji from University College London speak about his award-winning work at #ECTRIMS2022. Sarmad ...read more
ECTRIMS 2022 Best Young Investigator Award: Stephanie Meier
Watch Stephanie Meier of University Hospital Basel talk about how presenting her abstract at ECTRIMS ...read more
ECTRIMS 2022 Poster Winner Dr Victoria Leavitt
Watch last year’s Abstract Poster Winner Dr Vicky Leavitt from Columbia University Irving Medical Center ...read more
ECTRIMS 2022 Best Young Investigator Award: Annalisa Colombi
Watch Annalisa Colombi of Università degli Studi di Verona talk about how presenting her abstract ...read more
ECTRIMS: Supporting practice-changing research for almost four decades
Supporting and disseminating research are central to our mission at ECTRIMS, and that’s why, for ...read more
Episode 12: Access For All: Adding MS DMTs to the WHO Essential Medicines List
In 70% of countries, people face huge challenges in accessing MS disease modifying therapies (DMTs). ...read more
Rachel Horne Prize Applications Now Open
Submissions for the ECTRIMS’ supported “Rachel Horne Prize for Women’s Research in MS ...read more
Research Updates: March 2023
Latest developments in MS research: new study may help explain protective effects of pregnancy in ...read more
Episode 11: Using Real-World Studies to Compare DMTs in MS
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and ...read more
Diagnosis of MS: where are we and what do we need to improve?
The diagnosis of MS [1] typically relies on the presence of neurological signs and symptoms, ...read more
Healthcare is a right: Why we’re backing MSIF’s bid for affordable, equitable access to MS DMTs worldwide
Everyone with MS should have access to the treatment and care they need to live ...read more
Episode 10: Remyelination in MS: a New Clinical Trial
Will Brown and Alasdair Coles from University of Cambridge discuss remyelination in multiple sclerosis and ...read more
Research Updates: February 2023
Latest developments in MS research: Epstein-Barr virus as a cause of multiple sclerosis: opportunities for ...read more
From the blood to the brain, crossing an insuperable barrier
The integrity of the blood-brain barrier (BBB) is essential in protecting the brain [1] from ...read more
ECTRIMS backs MSIF’s bid to add MS disease-modifying therapies to WHO Essential Medicines List
ECTRIMS has joined the global MS community in endorsing MSIF’s bid to have MS DMTs ...read more
International Day of Women and Girls in Science: The Rachel Horne Prize
February 11 is a special day for the global science community. Worldwide, people come ...read more
Research Updates: January 2023
Latest developments in MS research: a recent study offers insights into gut bacteria & MS; ...read more
Episode 9: Stem Cell Research in Multiple Sclerosis
Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, explains ...read more
Shedding new light on the pathogenesis of MS
The underlying pathogenesis of MS remains an area of considerable interest and research and was ...read more
Episode 8 – ECTRIMS 2022: For People with MS – Part 3
MS Patient Experts Jana Hlavacova with the European Multiple Sclerosis Platform Young People’s Network and ...read more
Episode 7: ECTRIMS 2022: For People with MS – Part 2
Dr. Brigit de Jong from Amsterdam UMC and Professor Alan Thompson from Queens Square Institute ...read more
Episode 6: ECTRIMS 2022 For People With MS – Part 1
Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for ...read more
Can biomarkers help us move towards a more holistic approach to tackling MS?
The development and validation of biomarkers is essential to furthering our understanding of disease progression ...read more
Saúl Reyes on his ECTRIMS Fellowship Experience
Watch Saúl Reyes talk about how his Clinical Training Fellowship helped shape his career, as ...read more
Paula Tagliani on her ECTRIMS Fellowship experience
Watch Paula Tagliani speak about her 2019 Clinical Training Fellowship with ECTRIMS – as the ...read more
Mariano Cabezas Grebol on his ECTRIMS Fellowship experience
Watch Dr Mariano Cabezas Grebol talk about the key takeaways of his 2014 ECTRIMS-MAGNIMS fellowship, ...read more
ECTRIMS 2022 and the Evolution of the Treatment Arena for MS
As our knowledge and understanding of the underlying pathogenesis of MS increases, so the treatment ...read more
Özgür Yaldizli, 2012 ECTRIMS-MAGNIMS Fellow
Doctor Özgür Yaldizli, 2012 ECTRIMS-MAGNIMS Fellow, talks about this experience as an ECTRIMS Fellowship recipient, ...read more
International Advisory Committee on Clinical Trials in MS proposes new “mechanism-driven” framework to describe types of MS
Proposed framework moves away from purely clinical descriptions of separate phases, like relapsing-remitting, primary progressive, ...read more